The SWORD Study: A New Two-Drug Combo for HIV

Update: 2018-03-01

Description

Dr Paul Sax highlights the findings of the SWORD study of dolutegravir-rilpivirine and outlines the clinical implications.

Comments

In Channel

Here's What's New in the HIV Treatment Guidelines

2018-04-2005:28

This Novel, 1-Month Regimen to Prevent TB Is Practice-Changing

2018-03-2603:14

The SWORD Study: A New Two-Drug Combo for HIV

2018-03-0103:32

A Call for Early HIV Diagnosis

2018-01-2905:26

Oral HPV Infection Rate Is Alarmingly High in US Men

2018-01-2503:06

Protect Patients From a Surge in STDs

2018-01-1604:14

Shingles and Shingles Vaccine: An Update

2018-01-0505:49

Why Quarantine 'Makes No Sense' in Controlling HIV

2017-10-3003:27

Early HIV Therapy and Remission: 'Both Sides of the Coin'

2017-08-11--:--

A Front-Line Defense Against HIV in Hispanics/Latinos

2017-08-07--:--

Emerging Drug-Resistant Gonorrhea: What's New and What Now?

2017-03-0604:03

The World Is Not Prepared for Pandemics

2016-11-1503:04

'Same-Day' ART Initiation: Better Retention in Care, Outcomes

2016-09-2102:40

Using Video Games Instead of Drugs for Mental Health

2016-09-2018:17

Kaiser CEO Bernard Tyson on Balancing Technology and Human Touch

2016-09-0623:04

A Biotech Billionaire's Cancer 'Moonshot'

2016-04-2016:03

PrEP: Simple and Effective Yet Underused

2015-11-3004:18

The HIV/HCV Outbreak in Indiana

2015-08-2403:57

New HIV Testing Algorithm

2015-03-09--:--

HIV Care Saves Lives

2015-01-12--:--

00:00

1.0x

The SWORD Study: A New Two-Drug Combo for HIV

#box-pro-ellipsis-176236685628114{-webkit-line-clamp:2;}The SWORD Study: A New Two-Drug Combo for HIV

The SWORD Study: A New Two-Drug Combo for HIV

The SWORD Study: A New Two-Drug Combo for HIV